EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access · CC BY 4.0

Efficacy and Safety of Phase 1 of Very Low Energy Ketogenic Therapy (VLEKT) in Subjects with Obesity and Mild Renal Impairment

Ludovica Verde, Luigi Barrea iD, Martina Galasso, Stefania Lucà, Elisabetta Camajani iD, Antonio Pisani, Annamaria Colao, Massimiliano Caprio iD, Giovanna Muscogiuri

Nutrients · 2025

DOI: 10.3390/nu17040721 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Nutrients, 2025. Verfasst von Ludovica Verde und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Obesity, Diet, Ketogenic, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity impairs renal function through direct mechanisms, such as proinflammatory adipocytokine production, and indirect mechanisms, including obesity-related comorbidities. Despite the increasing prevalence of obesity and chronic kidney disease (CKD), clinical guidelines for their combined management remain lacking. Very Low Energy Ketogenic Therapy (VLEKT) has demonstrated efficacy in weight loss, but evidence on its safety and efficacy in individuals with obesity and mild renal impairment is limited. This study aimed to assess the efficacy and safety of Phase 1 of VLEKT in individuals with obesity and mild renal impairment.

Methods

This cross-sectional study included 73 individuals with overweight or obesity (mean age 53.7 ± 8.8 years; BMI 35.3 ± 4.2 kg/m2) and an estimated glomerular filtration rate (eGFR) of at least 60 mL/min/1.73 m2 (evaluated using the CKD-EPI equation). Anthropometric (weight, BMI, and waist circumference) and biochemical parameters (fasting plasma glucose, insulin, cholesterol profile, triglycerides, AST, ALT, and urea) were collected at baseline and after 45 (±2) days of Phase 1 of VLEKT.

Results

At baseline, 54.8% of participants had an eGFR

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityDiet, KetogenicRenal Insufficiency, ChronicHumansMiddle AgedMaleFemaleCross-Sectional StudiesGlomerular Filtration RateAdultTreatment OutcomeWeight LossBlood GlucoseBody Mass Index

Stichwörter der Autor:innen

HOMA-IRanthropometric parameterschronic kidney diseaseobesityrenal functionvery low energy ketogenic therapyweight loss

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
  • Department of Medicine, Division of Endocrinology, University of Arizona, Tucson, AZ 85724, USA.
  • Dipartimento di Psicologia e Scienze Della Salute, Università Telematica Pegaso, Centro Direzionale Isola F2, Via Porzio, 80143 Naples, Italy.
  • Dipartimento di Medicina Clinica e Chirurgia, Centro Italiano per la cura e il Benessere del Paziente con Obesità (C.I.B.O), Università degli Studi di Napoli Federico II, Via Sergio Pansini 5, 80131 Naples, Italy.
  • Distretto Sanitario 67, ASL Salerno, 84085 Salerno, Italy.
  • Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele, 00166 Rome, Italy.

ORCID-Profile: Luigi Barrea, Elisabetta Camajani, Massimiliano Caprio

Zitieren

APA

Verde, L., Barrea, L., Galasso, M., Lucà, S., Camajani, E., Pisani, A., Colao, A., Caprio, M., & Muscogiuri, G. (2025). Efficacy and Safety of Phase 1 of Very Low Energy Ketogenic Therapy (VLEKT) in Subjects with Obesity and Mild Renal Impairment. Nutrients. https://doi.org/10.3390/nu17040721

Vancouver

Verde L, Barrea L, Galasso M, Lucà S, Camajani E, Pisani A, et al. Efficacy and Safety of Phase 1 of Very Low Energy Ketogenic Therapy (VLEKT) in Subjects with Obesity and Mild Renal Impairment. Nutrients. 2025. doi:10.3390/nu17040721

BibTeX
@article{Verde2025,
  author = {Verde, Ludovica and Barrea, Luigi and Galasso, Martina and Lucà, Stefania and Camajani, Elisabetta and Pisani, Antonio and Colao, Annamaria and Caprio, Massimiliano and Muscogiuri, Giovanna},
  title = {Efficacy and Safety of Phase 1 of Very Low Energy Ketogenic Therapy (VLEKT) in Subjects with Obesity and Mild Renal Impairment},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17040721}
}
Kostenlos starten →